Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | HLA-DOA |
| Upstream (Parents) |
|---|
| (<<) ADRBK2 → HLA-DOA |
| (<<) ALPPL2 → HLA-DOA |
| (<<) BBC3 → HLA-DOA |
| (<<) BCL2L13 → HLA-DOA |
| (<<) ELF2 → HLA-DOA |
| (<<) EP300 → HLA-DOA |
| (<<) EPHB6 → HLA-DOA |
| (<<) FKSG2 → HLA-DOA |
| (<<) GALK1 → HLA-DOA |
| (<<) GALR3 → HLA-DOA |
| (<<) IGFBP2 → HLA-DOA |
| (<<) INVS → HLA-DOA |
| (<<) JAG1 → HLA-DOA |
| (<<) KCNJ2 → HLA-DOA |
| (<<) KLK10 → HLA-DOA |
| (<<) LARP6 → HLA-DOA |
| (<<) MPP1 → HLA-DOA |
| (<<) MT1G → HLA-DOA |
| (<<) NCOR2 → HLA-DOA |
| (<<) PITPNA → HLA-DOA |
| (<<) PKIA → HLA-DOA |
| (<<) POP1 → HLA-DOA |
| (<<) PRKCE → HLA-DOA |
| (<<) PTK2B → HLA-DOA |
| (<<) RNF5 → HLA-DOA |
| (<<) ROCK2 → HLA-DOA |
| (<<) RPL35 → HLA-DOA |
| (<<) SLC25A37 → HLA-DOA |
| (<<) SMURF1 → HLA-DOA |
| (<<) STAT5B → HLA-DOA |
| (<<) STK17A → HLA-DOA |
| (<<) STK17B → HLA-DOA |
| (<<) SYN1 → HLA-DOA |
| (<<) SYNJ2 → HLA-DOA |
| (<<) TSC22D1 → HLA-DOA |
| (<<) WWTR1 → HLA-DOA |
| Downstream (Children) |
|---|
| HLA-DOA → DUSP1 (>>) |
| HLA-DOA → FER1L4 (>>) |
| HLA-DOA → GRIN2D (>>) |
| HLA-DOA → IL1F7 (>>) |
| HLA-DOA → IL1RN (>>) |
| HLA-DOA → NRG1 (>>) |
| HLA-DOA → VANGL1 (>>) |
